Investigating the actions of bupropion on dependence-related effects of nicotine in rats

Psychopharmacology

Volumn 165, Issue 4, 2003, Pages 405-412

  Shoaib, Mohammed ^a   Sidhpura, Nimish ^a   Shafait, Sajid ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Bupropion; Dependence; Nicotine; Rat

Indexed keywords

AMFEBUTAMONE; NICOTINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONDITIONING; CONTROLLED STUDY; DOSE RESPONSE; DRUG MEGADOSE; DRUG SELF ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; TASTE AVERSION; TOBACCO DEPENDENCE;

EID: 0037320136     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-002-1277-x     Document Type: Article

References (35)

1. Ascher J, Cole J, Colin J, Feigher J, Ferris R, Fibiger J, Golden R, Martin P, Potter W, Richelson E, Sulser F (1995) Bupropion: a review of its mechanism of antidepressant activity. J Clin Psychiatry 56:395-401
2. Caine SB, Koob GF (1994) Effects of dopamine D-1 and D-2 antagonists on cocaine self-administration under different schedules of reinforcement in the rat. J Pharmacol Exp Ther 270:209-218
3. Chandler CJ, Stolerman IP (1999) Discriminative stimulus properties of the nicotinic agonist cytisine. Psychopharmacology 129:257-264
4. Damaj MI, Slemmer J, Carroll FI, Martin BR (1999) Pharmacological characterization of nicotine's interaction with cocaine and cocaine analogs. J Pharmacol Exp Ther 289:1229-1236
5. Ferris R, Cooper B, Maxwell R (1983) Studies of bupropion's mechanism of antidpressant activity. J Clin Psychiatry 44:74-78
6. Findlay J, Van Wyck Fleet J, Smith P, Butz R, Hinton M, Blum M (1981) Pharmacokinetics of bupropion, a novel antidepressant agent, following oral administration to healthy subjects. Eur J Clin Pharmacol 21:127-135
7. Fryer J, Lukas R (1999) Noncompetitive functional inhibition at diverse human nicotinic acetylcholine receptor subtypes by bupropion, phencyclidine and ibogaine. J Pharmacol Exp Ther 288:88-92
8. Grigson PS (1997) Conditioned taste aversions and drugs of abuse: a reinterpretation. Behav Neurosci 111:129-136
9. Hayford K, Patten C, Rummans T, Schroeder D, Offord K, Croghan I, Glover E, Sachs D, Hurt R (1999) Efficacy of bupropion for smoking cessation in smokers with a former history of major depression. Br J Psychiatry 174:173-178
10. Hurt R, Sachs D, Glover P, Sullivan C, Croghan I, Sullivan P (1997) A comparison of sustained-release bupropion and placebo for smoking cessation. N Engl J Med 337:1195-1202
11. Hysu P-H, Singh A, Giargiari T, Dunn J, Ascher J, Johnston J (1997) Pharmacokinetics of bupropion and its metabolites in cigarette smokers versus non-smokers. J Clin Psychiatry 37:737-743
12. Iwamoto ET, Williamson EC (1984) Nicotine-induced taste aversion: characterization and preexposure effects in rats. Pharmacol Biochem Behav 21:527-532
13. Jorenby DE, Leischow S, Nides M, Rennard S, Johnston J, Hughes A, Smith S, Muramoto M, Daughton D, Doan K, Fiore M, Baker T (1999) A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation. N Engl J Med 340:685-691
14. Kumar R, Stolerman IP (1977) Experimental and clinical aspects of drug dependence. In: Iversen LL, Iversen SD, Snyder SH (eds) Handbook of psychopharmacology, vol 7. Plenum Press, New York, pp 321-367
15. Kumar R, Pratt JA, Stolerman IP (1983) Characteristics of conditioned taste aversion produced by nicotine in rats. Br J Pharmacol 79:245-253
16. Lake JR, Montellano AL, Presley SE, Meyers-Paal RL, Perales BA, Olivier M, Malin DH (2001) Acute bupropion dose-dependently reduces nicotine abstinence syndrome in the rat. Soc Neurosci Abstr pp 667.7
17. Mansbach RS, Rovetti C, Freedland C (1998) The role of monoamine neurotransmitter systems in the nicotine discriminative stimulus. Drug Alcohol Depend 52:125-134
18. Prada JA, Goldberg SR (1985) Effects of caffeine or nicotine pretreatments on nicotine self-administration by the squirrel monkey. Pharmacologist 27:226
19. Rose JE, Corrigall WA (1997) Nicotine self-administration in animals and humans: similarities and differences. Psychopharmacology 130:28-40
20. Russell MAH (1979) Tobacco dependence: is nicotine rewarding or aversive? In: Krasnegor NA (ed) NIDA research monograph 23. Department of Health, Education and Welfare, Washington D.C. pp 100-122
21. Schuster CR, Balster RL (1977) The discriminative stimulus properties of drugs. In: Thompson T, Dews PB (eds) Advances in behavioural pharmacology, vol 1. Academic Press, New York, pp 85-138
22. Shiffman S, Johnston J, Khayrallah M, Elash C, Gwaltney C, Paty J, Gnys M, Evoniuk G, DeVeaugh-Geiss J (2000) The effect of bupropion on nicotine craving and withdrawal. Psychopharmacology 148:33-40
23. Shoaib M, Schindler CW, Goldberg SR (1997) Nicotine self-administration in rats: strain and nicotine pre-exposure effects on acquisition. Psychopharmacology 129:35-43
24. Shoaib M, Swanner L, Yasar S, Goldberg SR (1999) Chronic caffeine exposure potentiates nicotine self-administration in rats. Psychopharmacology 142:327-333
25. Shoaib M, Zubaran C, Stolerman IP (2000) Antagonism of stimulus properties of nicotine by dihydro-beta-erythroidine in rats. Psychopharmacology 149:140-146
26. Slemmer J, Martin BR, Damaj MI (2000) Bupropion is a nicotinic antagonist. J Pharmacol Exp Ther 295:321-327
27. Stolerman IP (1990) Behavioural pharmacology of nicotine in animals. In: Wonnacott S, Russell MAH, Stolerman IP (eds) Nicotine psychopharmacology: molecular, cellular and behavioural aspects. Oxford Science Publications, Oxford, pp 278-306
28. Stolerman IP, D'Mello GD (1981) Oral self-administration and the relevance of conditioned taste aversions. In: Thompson T, Dews PB, McKim WA (eds) Advances in behavioural pharmacology. Academic Press, New York, pp 169-214
29. Stolerman IP, Pratt JA, Garcha HS, Giardini V, Kumar R (1983) Nicotine cue in rats analysed with drugs acting on cholinergic and 5-hydroxytryptamine mechanisms. Neuropharmacology 22:1029-1037
30. Stolerman IP, Garcha HS, Pratt JA, Kumar R (1984) Role of training dose in discrimination of nicotine and related compounds by rats. Psychopharmacology 84:413-419
31. Stolerman IP, Chandler CJ, Garcha HS, Newton JM (1997) Selective antagonism of behavioural effects of nicotine by dihydro-beta-erythroidine in rats. Psychopharmacology 129:390-397
32. Suckow R, Smith T, Perumal A, Cooper T (1986) Pharmacokinetics of bupropion and metabolites in plasma and brain of rats, mice, and guinea pigs. Drug Metab Dispos 14:692-697
33. Watkins SS, Epping-Jordan MP, Koob GF, Markou A (1999) Blockade of nicotine self-administration with nicotinic antagonists in rats. Pharmacol Biochem Behav 62:743-751
34. Welch R, Lai A, Schroeder D (1987) Pharmacological sugnificance of the species differences in bupropion metabolism. Xenobiotica 17:287-298
35. Winer BJ (1971) Statistical principles in experimental design, 2nd edn. McGraw-Hill, New York